BIOVIE INC (BIVI)
US09074F2074 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to BIVI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 168.42% above the current price.
BIVI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BIVI.
In the previous month the buy percentage consensus was at a similar level.
BIVI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-01 | ThinkEquity | Initiate | Buy |
| 2023-11-30 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-17 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-02-14 | Oppenheimer | Reiterate | Outperform |
| 2022-09-28 | EF Hutton | Maintains | Buy |
| 2022-07-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-11-30 | B. Riley Securities | Maintains | Buy |